Differential diagnosis and management of anemia in the newborn

Pediatric Clinics of North America

Volumn 51, Issue 4, 2004, Pages 1087-1107

  Bizzarro, Matthew J ^a,b   Colson, Eve ^b   Ehrenkranz, Richard A ^a,b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ADRENAL DISEASE; ALPHA TOCOPHEROL DEFICIENCY; ANAMNESIS; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW DISEASE; BRAIN HEMORRHAGE; DELIVERY; DIAGNOSTIC TEST; ERYTHROCYTE MEMBRANE; ERYTHROCYTE TRANSFUSION; FETOMATERNAL TRANSFUSION; FETOPLACENTAL UNIT; HEMATOCRIT; HEMOGLOBINOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY RUPTURE; LEUKEMIA; LIVER RUPTURE; METABOLIC DISORDER; NEWBORN ANEMIA; NUTRITIONAL DEFICIENCY; OBSTETRICS; PHYSICAL EXAMINATION; PLACENTA DISORDER; PRENATAL PERIOD; REVIEW; RUBELLA; SEPSIS; SPLEEN RUPTURE; SYPHILIS; THALASSEMIA; TWIN TWIN TRANSFUSION SYNDROME; UMBILICAL CORD; VIRUS INFECTION;

EID: 3242660182     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2004.03.006     Document Type: Review

References (81)

1. Zaizov R, Mamoth Y. Red cell values on the first postnatal day during the last 16 weeks of gestation. Am J Hematol 1976;1(2):275-8.
2. Forestier F, Daffos F, Galacteros F, Bardakjian J, Rainaut M, Beuzard Y. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986;20(4):342-6.
3. Matoth Y, Zaizov R, Varsano I. Postnatal changes in some red cell parameters. Acta Paediat Scand 1971;60(3):317-23.
4. Gairdner D, Marks J, Roscoe JD. Blood formation in infancy: part II. normal erythropoiesis. Arch Dis Child 1952;27(133):214-21.
5. Luchtman-Jones L, Schwartz AL, Wilson DB. The blood and hematopoietic system. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine. Disorders of the fetus and infant. 7th edition. St. Louis (MO): Mosby; 2002. p. 1182-254.
6. Usher R, Shephard M, Lind J. The blood volume of the newborn infant and placental transfusion. Acta Paediatr 1963;52:497-512.
7. Linderkamp O, Versmold HT, Strohhacker I, Messow-Zahn K, Riegel KP, Betke K. Capillary-venous hematocrit differences in newborn infants. Eur J Pediatr 1977;127(1):9-14.
8. Kirkman HN, Riley HD. Posthemorrhagic anemia and shock in the newborn: a review. Pediatrics 1959;24(1):97-105.
9. Wallgren G, Hanson JS, Lind J. Quantitative studies of the human neonatal circulation. III. Observations on the newborn infant's central circulatory response to moderate hypovolemia. Acta Paediatr Scand 1967;179(Suppl):43-54.
10. Lubin B. Neonatal anaemia secondary to blood loss. Clin Haematol 1978;7(1):19-34.
11. Cohen F, Zuelzer WW, Gustafson DC, Evans MM. Mechanism of isoimmunization. I. The transplacental passage of fetal erythrocytes in homospecific pregnancies. Blood 1964;23(5):621-46.
12. Scott JR, Warenski JC. Tests to detect and quantitate fetomaternal bleeding. Clin Obstet Gynecol 1982;25(2):277-82.
13. Pai MKR, Bedritis I, Zipursky A. Massive transplacental hemorrhage: clinical manifestations in the newborn. CMAJ 1975;112(5):585-9.
14. Zipursky A, Hull A, White FD, Israels LG. Foetal erythrocytes in the maternal circulation. Lancet 1959;1:451-2.
15. Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv 1997;52(6):372-80.
16. Wentworth P. A placental lesion to account for foetal hemorrhage into the maternal circulation. J Obstet Gynaecol Br Commonw 1964;71(3):379-87.
17. van Gemert MJ, Umur A, Tjissen JG, Ross MG. Twin-twin transfusion syndrome: etiology, severity and rational management. Curr Opin Obstet Gynecol 2001;13(2):193-206.
18. Bernirschke K. Accurate recording of twin placenta. Obstet Gynecol 1961;18(3):334-47.
19. Becker AH, Glass H. Twin-to-twin transfusion syndrome. Am J Dis Child 1963;106:624-9.
20. Naeye RL. Human intrauterine parabiotic syndrome and its complications. N Engl J Med 1963;268(15):804-9.
21. Rausen AR, Seki M, Strauss L. Twin transfusion syndrome. J Pediatr 1965;66(3):613-28.
22. Nebesky O. Beitrag zur Nabelschurzerreissung intra partum [Umbilical cord rupture in the intrapartum period]. Arch Gynakol 1913;100:601-40.
23. Smith JJ, Benjamin F. Posthemorrhagic anemia and shock in the newborn at birth. Obstet Gynecol Surv 1968;23(6):511-21.
24. Earn AA. The effect of congenital abnormalities of the umbilical cord and placenta on the newborn and mother. J Obstet Gynaecol Br Emp 1951;58(3):456-9.
25. Kouyoumdjian A. Velamentous insertion of the umbilical cord. Obstet Gynecol 1980;56(6):737-42.
26. Mabie WC. Placenta previa. Clin Perinatol 1992;19(2):425-35.
27. Molteni RA. Perinatal blood loss. Pediatr Rev 1990;12(2):47-54.
28. Barrow E, Peters R. Exsanguinating hemorrhage into the scalp in newborn infants. S Afr Med J 1968;42(11):265-7.
29. Chadwick LM, Pemberton PJ, Kurinczuk JJ. Neonatal subgaleal haematoma: associated risk factors, complications and outcome. J Paediatr Child Health 1996;32(3):228-32.
30. Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med 1999;341(23):1709-14.
31. Robinson RJ, Rossiter MA. Massive subaponeurotic hemorrhage in babies of African origin. Arch Dis Child 1968;43(232):684-7.
32. Tsiantos A, Victorin L, Relier JP, Dyer N, Sundell H, Brill AB, et al. Intracranial hemorrhage in the prematurely born infant. Timing of clots and the evaluation of signs and symptoms. J Pediatr 1974;85(6):854-6.
33. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. 5th edition. Philadelphia: WB Saunders Company; 1998. p. 237-335.
34. Alter BP. Fanconi's anemia: current concepts. Am J Pediatr Hematol Oncol 1992;14(2):170-6.
35. Alter BP, Potter NU. Long-term outcome in Fanconi's anemia: description of 26 cases and a review of the literature. In: Geman J, editor. Chromosome mutation and neoplasia. New York: Alan R. Liss, Inc.; 1983. p. 43-62.
36. Young NS, Alter BP. Aplastic anemia: acquired and inherited. Philadelphia: WB Saunders Company; 1994.
37. Alter BP, Nathan DG. Red cell aplasia in children. Arch Dis Child 1979;54(2):263-7.
38. Diamond LK,Wang WC, Alter BP. Congenital hypoplastic anemia. Adv Pediatr 1976;22:349-78.
39. Diamond LK, Allen DM. Congenital (erythroid) hypoplastic anemia. Am J Dis Child 1961;102(Suppl):149-61.
40. Gallagher PG, Ehrenkranz RA. Nutritional anemias in infancy. Clin Perinatol 1995;22(3):671-92.
41. 12. In: Tsang RC, Nichols BL, editors. Infant nutrition. Philadelphia: Hanley & Belfus; 1988. p. 216-35.
42. 12. In: Tsang RC, Lucas A, Uauy R, editors. Nutritional needs of the preterm infant: scientific basis and practical guidelines. Baltimore (MD): Williams & Williams; 1993. p. 177-94.
43. Hoffbrand AV. Folate deficiency in premature infants. Arch Dis Child 1970;45(242):441-4.
44. Pearson HA. Life-span of the fetal red blood cell. J Pediatr 1967;70(2):166-71.
45. Manco-Johnson M, Rodden DJ, Collins S. Newborn hematology. In: Merenstein GB, Gardner SL, editors. Handbook of neonatal intensive care. 5th edition. St. Louis (MO): Mosby; 2002. p. 419-42.
46. Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991;265(24):3270-4.
47. Glader BE, Platt O. Haemolytic disorders of infancy. Clin Haematol 1978;7(1):35-61.
48. Prokop O, Uhlenbruck G. Rhesus blood groups. In: Prokop O, Uhlenbruck G, editors. Human blood and serum groups. New York: Wiley Interscience; 1969. p. 169-220.
49. Zipursky A. Isoimmune hemolytic disease. In: Nathan DG, Oski FA, editors. Hematology of infancy and childhood. 4th edition. Philadelphia: WB Saunders Company; 1994. p. 44.
50. Wolfe LC. Neonatal anemia. In: Handin RI, Lux SE, Stossel TP, editors. Blood. Principles and practices of hematology. Philadelphia: JB Lippincott Company; 1995. p. 2105-30.
51. Mayne S, Parker JH, Harden TA, Dodds SD, Beale JA. Rate of RhD sensitization before and after implementation of a community based antenatal prophylaxis programme. BMJ 1997;315(7122):1588.
52. Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1968;118(6):623-7.
53. Thompson PJ, Greenough A, Brooker R, Nicolaides KH, Gamsu HR. Antenatal diagnosis and outcome in hydrops fetalis. J Perinat Med 1993;21(1):63-7.
54. Van Maldergem L, Jauniaux E, Fourneau C, Gillerot Y. Genetic causes of hydrops fetalis. Pediatrics 1992;89(1):81-6.
55. Blanchette VS, Zipursky A. Assessment of anemia in newborn infants. Clin Perinatol 1984;11(2):489-510.
56. Mollison PL. Blood transfusion in clinical medicine. 6th edition. Oxford: Blackwell Scientific Publication, Inc.; 1979.
57. Voak D, Williams MA. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells. Br J Haematol 1971;20(1):9-23.
58. Benz Jr EJ. The erythrocyte membrane and cytoskeleton: structure, function, and disorder. In: Stamatoyannopoulos G, editor. The molecular basis for blood diseases. 2nd edition. Philadelphia: WB Saunders Company; 1994. p. 257.
59. Gallagher PG, Forget BG, Lux SE. Disorders of the erythrocyte membrane. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. 5th edition. Philadelphia: WB Saunders Company; 1998. p. 544-644.
60. Stamey CC, Diamond LK. Congenital hemolytic anemia in the newborn. Am J Dis Child 1957;94:616-22.
61. Trucco JI, Brown AK. Neonatal manifestations of hereditary spherocytosis. Am J Dis Child 1967;113(2):263-70.
62. Burman D. Congenital spherocytosis in infancy. Arch Dis Child 1958;33(170):335-41.
63. Glele-Kakai C, Garbarz M, Lecomte MC, Leborgne S, Galand C, Bournier O, et al. Epidemiological studies of spectrin mutations related to hereditary elliptocytosis and spectrim polymorphisms in Benin. Br J Hemaetol 1996;95(1):57-66.
64. Lecomte MC, Dhermy D, Gautero H, Bournier O, Galand C, Boivin P. Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants. C R Acad Sci III 1988;306(2):43-6.
65. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1991;324(3):169-74.
66. Mentzer WC. Pyruvate kinase deficiency and disorders of glycolysis. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. 5th edition. Philadelphia: WB Saunders Company; 1998. p. 665-703.
67. Liebhaber SA. α thalassemia. Hemoglobin 1989;13(7,8):685-731.
68. Koenig HM, Vedvidk TS, Dozy AM, Golbus MS, Kan YW. Prenatal diagnosis of hemoglobin H disease. J Pediatr 1978;92(2):278-81.
69. Pearson HA. Anemia in the newborn: a diagnostic approach and challenge. Semin Perinatol 1991;15(3):2-8.
70. Oska FA. Normal blood values in the newborn period. In: Oski FA, Naiman JL, editors. Hematologic problems in the newborn. 2nd edition. Philadelphia: WB Saunders Company; 1972. p. 13.
71. Oski FA, Brugnara C, Nathan DG. A diagnostic approach to the anemic patient. In: Nathan DG, Orkin SH, editors. Hematology of infancy and childhood. 5th edition. Philadelphia: WB Saunders Company; 1998. p. 375-84.
72. Zipursky A, Brown E, Palko J, Brown EJ. The erythrocyte differential count in newborn infants. Am J Pediatr Hematol Oncol 1983;5(1):45-51.
73. Blank JP, Sheagren TG, Vajaria J, Mangurten HH, Benwara RS, Puppala BL. The role of RBC transfusion in the premature infant. Am J Dis Child 1984;138(9):831-3.
74. Ransome OJ, Moosa EA, Mothebe FM. Spector I. Are regular "top-up" transfusions necessary in otherwise well, growing premature infants? S Afr Med J 1989;75(4):165-6.
75. Luchtman-Jones L, Schwartz AL, Wilson DB. Blood component therapy for the neonate. In: Fanaroff AA, Martin RJ, editors. Neonatal-perinatal medicine. Disorders of the fetus and infant. 7th edition. St. Louis (MO): Mosby; 2002. p. 1239-54.
76. Dodd RY. Transfusion-transmitted hepatitis virus infection. Hematol Oncol Clin North Am 1995;9(1):137-54.
77. Dodd RY. The risk of transfusion transmitted infection. N Engl J Med 1992;327(6):419-20.
78. Delage G. Transfusion-transmitted infections in the newborn. Transfus Med Rev 1995;9(3):271-6.
79. Liu EA, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited donor exposure program for premature infants. J Pediatr 1994;125(1):92-6.
80. Barret F, Elbert F, Pittner B, Cordle D, Goeken N, Strauss RG. Are mothers dangerous directed donors for their infants? Transfusion 1989;29(Suppl):59S-214S.
81. Strauss RG, Sacher RA. Directed donations for pediatric patients. Transfus Med Rev 1988;2(2):58-64.